MEDIROM Healthcare Technologies Inc. (MRM)

NASDAQ: MRM · Real-Time Price · USD

Compare

1.480

-0.050 (-3.27%)

At close: Jan 30, 2026, 4:00 PM EST

1.470

-0.010 (-0.68%)

After-hours: Jan 30, 2026, 7:43 PM EST

MRM Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	7,885	8,146	6,628	6,560	5,366	3,316
Other Revenue	181.89	153.63	200.4	393.77	43.97	25.67
Revenue	8,067	8,299	6,828	6,954	5,410	3,342
Revenue Growth (YoY)	12.79%	21.55%	-1.81%	28.54%	61.89%	-14.50%
Cost of Revenue	6,046	6,053	5,259	5,052	3,994	2,913
Gross Profit	2,021	2,246	1,569	1,902	1,415	428.95
Selling, General & Admin	2,218	2,242	1,960	1,805	1,811	1,069
Operating Expenses	2,218	2,242	1,960	1,805	1,811	1,069
Operating Income	-196.75	4.77	-391.58	96.97	-395.38	-639.59
Interest Expense	-55.13	-49.75	-36.87	-9.8	-11.95	-13.23
Interest & Investment Income	0.06	0.01	1.11	6.07	0.84	1.33
Currency Exchange Gain (Loss)	18.12	18.12	26.83	14.83	14.99	-
Other Non Operating Income (Expenses)	118.6	56.8	7.45	71.7	52.22	131.3
EBT Excluding Unusual Items	-115.1	29.95	-393.06	179.77	-339.27	-520.19
Merger & Restructuring Charges	-	-	-	-	-12	-
Gain (Loss) on Sale of Assets	164.2	40.63	413.68	-	-	-
Asset Writedown	-107.46	-22.87	-	-	-63.21	-106.5
Pretax Income	-58.35	47.71	20.62	179.77	-414.48	-626.69
Income Tax Expense	-93.95	-90.48	-94.43	30.81	576.25	-87.52
Earnings From Continuing Operations	35.6	138.19	115.05	148.97	-990.73	-539.17
Net Income to Company	-	138.19	115.05	148.97	-990.73	-539.17
Minority Interest in Earnings	4.87	10.57	0.36	-	-	-
Net Income	40.47	148.76	115.4	148.97	-990.73	-539.17
Net Income to Common	40.47	148.76	115.4	148.97	-990.73	-539.17
Net Income Growth	-	28.91%	-22.53%	-	-	-
Shares Outstanding (Basic)	7	5	5	5	5	4
Shares Outstanding (Diluted)	7	6	5	5	5	4
Shares Change (YoY)	50.05%	13.26%	-5.56%	12.16%	21.19%	-5.80%
EPS (Basic)	6.13	29.13	23.64	30.54	-203.13	-133.97
EPS (Diluted)	6.13	28.52	22.34	27.23	-203.13	-133.97
EPS Growth	-	27.65%	-17.96%	-	-	-
Free Cash Flow	-967.07	-1,403	-767.58	-806.44	-652.88	-439.98
Free Cash Flow Per Share	-131.62	-239.78	-148.56	-147.41	-133.86	-109.32
Gross Margin	25.05%	27.07%	22.98%	27.36%	26.16%	12.84%
Operating Margin	-2.44%	0.06%	-5.73%	1.39%	-7.31%	-19.14%
Profit Margin	0.50%	1.79%	1.69%	2.14%	-18.31%	-16.13%
Free Cash Flow Margin	-11.99%	-16.91%	-11.24%	-11.60%	-12.07%	-13.17%
EBITDA	149.08	294.81	-138.98	281.02	-269.13	-577.3
EBITDA Margin	1.85%	3.55%	-2.04%	4.04%	-4.98%	-17.28%
D&A For EBITDA	345.83	290.04	252.6	184.06	126.24	62.29
EBIT	-196.75	4.77	-391.58	96.97	-395.38	-639.59
EBIT Margin	-2.44%	0.06%	-5.73%	1.39%	-7.31%	-19.14%
Effective Tax Rate	-	-	-	17.14%	-	-
Revenue as Reported	8,067	8,299	6,828	6,954	5,410	3,342
Advertising Expenses	-	155.36	162.03	135.13	130.96	92.46

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q